Compare, Analyse ALEMBIC PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
ALEMBIC PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs664372-   
Low Rs412268-   
Sales per share (Unadj.) Rs208.7110.6-  
Earnings per share (Unadj.) Rs31.0-27.9-  
Cash flow per share (Unadj.) Rs37.1-23.1-  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.286.8-  
Shares outstanding (eoy) m188.52168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.62.9 89.1%   
Avg P/E ratio x17.4-11.5 -151.2%  
P/CF ratio (eoy) x14.5-13.9 -104.7%  
Price / Book Value ratio x3.73.7 101.2%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,46154,029 187.8%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m7,4673,391 220.2%   
Avg. sales/employee Rs ThNM4,349.7-  
Avg. wages/employee Rs ThNM789.9-  
Avg. net profit/employee Rs ThNM-1,096.0-  
INCOME DATA
Net Sales Rs m39,34718,673 210.7%  
Other income Rs m94131 71.7%   
Total revenues Rs m39,44118,804 209.7%   
Gross profit Rs m8,736-3,236 -270.0%  
Depreciation Rs m1,152806 143.0%   
Interest Rs m184506 36.4%   
Profit before tax Rs m7,493-4,417 -169.6%   
Minority Interest Rs m11-12 -87.7%   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568276 567.9%   
Profit after tax Rs m5,844-4,705 -124.2%  
Gross profit margin %22.2-17.3 -128.1%  
Effective tax rate %20.9-6.2 -334.8%   
Net profit margin %14.9-25.2 -58.9%  
BALANCE SHEET DATA
Current assets Rs m19,57713,677 143.1%   
Current liabilities Rs m14,8967,695 193.6%   
Net working cap to sales %11.932.0 37.1%  
Current ratio x1.31.8 73.9%  
Inventory Days Days90111 80.9%  
Debtors Days Days45124 36.6%  
Net fixed assets Rs m27,0977,972 339.9%   
Share capital Rs m37787 434.8%   
"Free" reserves Rs m26,8110-   
Net worth Rs m27,18814,656 185.5%   
Long term debt Rs m4,9935,151 96.9%   
Total assets Rs m47,77827,687 172.6%  
Interest coverage x41.7-7.7 -539.3%   
Debt to equity ratio x0.20.4 52.3%  
Sales to assets ratio x0.80.7 122.1%   
Return on assets %12.6-15.2 -83.2%  
Return on equity %21.5-32.1 -67.0%  
Return on capital %23.6-19.8 -119.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m13,3880-   
CASH FLOW
From Operations Rs m8,1201,594 509.4%  
From Investments Rs m-7,556-489 1,543.9%  
From Financial Activity Rs m5904,674 12.6%  
Net Cashflow Rs m1,1535,779 20.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.13 Rs / ZAR

Compare ALEMBIC PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: FDC  BIOCON   VENUS REMEDIES  DISHMAN PHARMA  IPCA LABS  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views On News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ALEMBIC PHARMA SHARE PRICE


Apr 9, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS